Brinker Capital Investments’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.22M Sell
4,191
-270
-6% -$125K 0.02% 742
2026
Q1
$2.14M Buy
4,461
+211
+5% +$108K 0.02% 732
2025
Q4
$2.39M Buy
4,250
+691
+19% +$392K 0.02% 754
2025
Q3
$1.83M Sell
3,559
-1,158
-25% -$506K 0.01% 881
2025
Q2
$1.48M Buy
4,717
+147
+3% +$44.1K 0.01% 956
2025
Q1
$1.39M Buy
4,570
+322
+8% +$108K 0.01% 905
2024
Q4
$1.41M Buy
4,248
+3,299
+348% +$1.12M 0.01% 872
2024
Q3
$317K Buy
949
+407
+75% +$155K ﹤0.01% 1510
2024
Q2
$223K Buy
542
+17
+3% +$6.73K ﹤0.01% 1591
2024
Q1
$212K Sell
525
-316
-38% -$111K ﹤0.01% 1596
2023
Q4
$256K Buy
+841
New +$227K ﹤0.01% 1476
2023
Q1
– Sell
-1,074
Closed -$228K – 1623
2022
Q4
$228K Buy
+1,074
New +$215K ﹤0.01% 1250
2022
Q1
– Sell
-1,198
Closed -$261K – 1405
2021
Q4
$261K Buy
+1,198
New +$251K ﹤0.01% 1297

Other funds holding MEDP

Brinker Capital Investments's MEDP Position: Q2 2026 in Review

Brinker Capital Investments reduced its Medpace (MEDP) stake by 6.1% in Q2 2026, selling an estimated $125K and leaving 4,191 shares worth $2.22M. The position accounts for 0.02% of the portfolio, ranked #742.

Brinker Capital Investments first reported a position in MEDP in Q4 2021 and has held it in 13 quarters since. The position peaked at $2.39M in Q4 2025. 700 funds tracked by Wall St. Rank hold MEDP as of Q2 2026.

  • Brinker Capital Investments held 4,191 shares of Medpace worth $2.22M as of Q2 2026.
  • Brinker Capital Investments sold 270 Medpace shares in Q2 2026, an estimated $125K.
  • Medpace made up 0.02% of Brinker Capital Investments's portfolio in Q2 2026, its #742 holding.
  • Brinker Capital Investments first reported a position in Medpace in Q4 2021 and has held it in 13 quarters since.
  • Brinker Capital Investments's Medpace position peaked at $2.39M in Q4 2025.
  • 700 funds tracked by Wall St. Rank held Medpace as of Q2 2026.

Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.